EGR1
Early growth response protein 1
Also known as: 225, AT225, EGR1_HUMAN, G0S30, KROX-24, NGFI-A, TIS8, ZIF-268
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P18146
- Gene
- EGR1
- Ensembl
- ENSG00000120738
- Chromosome
- 5
- Canonical length
- 543 aa
- Protein class
- Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
The protein encoded by this gene belongs to the EGR family of C2H2-type zinc-finger proteins. It is a nuclear protein and functions as a transcriptional regulator. The products of target genes it activates are required for differentitation and mitogenesis. Studies suggest this is a cancer suppressor gene. [provided by RefSeq, Dec 2014]
Canonical amino-acid sequenceUniProt
543 residues, UniProt reviewed canonical sequence.
>P18146|EGR1
1 MAAAKAEMQL MSPLQISDPF GSFPHSPTMD NYPKLEEMML LSNGAPQFLG AAGAPEGSGS
61 NSSSSSSGGG GGGGGGSNSS SSSSTFNPQA DTGEQPYEHL TAESFPDISL NNEKVLVETS
121 YPSQTTRLPP ITYTGRFSLE PAPNSGNTLW PEPLFSLVSG LVSMTNPPAS SSSAPSPAAS
181 SASASQSPPL SCAVPSNDSS PIYSAAPTFP TPNTDIFPEP QSQAFPGSAG TALQYPPPAY
241 PAAKGGFQVP MIPDYLFPQQ QGDLGLGTPD QKPFQGLESR TQQPSLTPLS TIKAFATQSG
301 SQDLKALNTS YQSQLIKPSR MRKYPNRPSK TPPHERPYAC PVESCDRRFS RSDELTRHIR
361 IHTGQKPFQC RICMRNFSRS DHLTTHIRTH TGEKPFACDI CGRKFARSDE RKRHTKIHLR
421 QKDKKADKSV VASSATSSLS SYPSPVATSY PSPVTTSYPS PATTSYPSPV PTSFSSPGSS
481 TYPSPVHSGF PSPSVATTYS SVPPAFPAQV SSFPSSAVTN SFSASTGLSD MTATFSPRTI
541 EICLocalizationUniProt · AlphaFold · HPA
Whether an antibody against EGR1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.66
- Highest tissue expression
- 729 nTPM
Expression across tissuesHPA
Tissue
- ovary: 729 nTPM
- thyroid gland: 548 nTPM
- adipose tissue: 530 nTPM
- fallopian tube: 512 nTPM
- smooth muscle: 443 nTPM
- blood vessel: 352 nTPM
Single-cell type
- epididymal basal cells: 1,777 nCPM
- thymic myoid cells: 1,354 nCPM
- ovarian stromal cells: 1,277 nCPM
- medullary thymic epithelial cells: 1,219 nCPM
- neutrophils: 1,199 nCPM
- smooth muscle cells: 1,103 nCPM
Immune cell
- neutrophil: 7.1 nTPM
- intermediate monocyte: 3.6 nTPM
- classical monocyte: 2.6 nTPM
- non-classical monocyte: 1.2 nTPM
- memory B-cell: 0.7 nTPM
- myeloid DC: 0.7 nTPM
Brain region
- cerebellum: 273 nTPM
- cerebral cortex: 151 nTPM
- hypothalamus: 72 nTPM
- hippocampal formation: 54 nTPM
- white matter: 47 nTPM
- basal ganglia: 42 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about EGR1.
Disease | ImmuneIEDB
Conditions an epitope on EGR1 was assayed in.
- narcolepsy B cell
- multiple sclerosis B cell
- peripheral nervous system disease B cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.59
- gnomAD pLI
- 0.35
- gnomAD missense Z
- 1.9
- DepMap mean gene effect
- -0.07
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- BMP signaling pathway
- cellular response to gamma radiation
- cellular response to heparin
- cellular response to hypoxia
- cellular response to mycophenolic acid
- circadian regulation of gene expression
- circadian temperature homeostasis
- estrous cycle
- interleukin-1-mediated signaling pathway
- locomotor rhythm
- negative regulation of canonical Wnt signaling pathway
- negative regulation of transcription by RNA polymerase II
- positive regulation of chemokine production
- positive regulation of DNA-templated transcription
- positive regulation of gene expression
- positive regulation of gene expression via chromosomal CpG island demethylation
- positive regulation of hormone biosynthetic process
- positive regulation of interleukin-1 beta production
- positive regulation of miRNA transcription
- positive regulation of transcription by RNA polymerase II
- regulation of neuron apoptotic process
- regulation of progesterone biosynthetic process
- regulation of transcription by RNA polymerase II
- response to glucose
- response to hypoxia
- response to insulin
- response to ischemia
- skeletal muscle cell differentiation
- T cell differentiation
- cellular response to interleukin-8
- glomerular mesangial cell proliferation
- positive regulation of glomerular metanephric mesangial cell proliferation
- positive regulation of post-translational protein modification
- regulation of protein sumoylation
Molecular functions
- DNA binding
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity
- DNA-binding transcription factor activity, RNA polymerase II-specific
- double-stranded methylated DNA binding
- hemi-methylated DNA-binding
- histone acetyltransferase binding
- promoter-specific chromatin binding
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- RNA polymerase II transcription regulatory region sequence-specific DNA binding
- sequence-specific DNA binding
- sequence-specific double-stranded DNA binding
- transcription cis-regulatory region binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Zinc finger C2H2-type
- Early growth response, N-terminal
- Zinc finger C2H2 superfamily
- Zinc finger, C2H2 type
- Early growth response N-terminal domain
- Early growth response protein 1, C-terminal
- Domain of unknown function (DUF3432)
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of EGR1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads EGR1 as an antibody target. Whether an autoantibody or antibody against EGR1 could matter depends on whether native EGR1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
EGR1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label EGR1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...